132 related articles for article (PubMed ID: 30122837)
1. Apelin-13: A Promising Biomarker for Multiple Sclerosis?
Alpua M; Turkel Y; Dag E; Kisa U
Ann Indian Acad Neurol; 2018; 21(2):126-129. PubMed ID: 30122837
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of CTRP-3, CTRP-9 and apelin in women with multiple sclerosis.
Rasooli Tehrani A; Gholipour S; Sharifi R; Yadegari S; Abbasi-Kolli M; Masoudian N
J Neuroimmunol; 2019 Aug; 333():576968. PubMed ID: 31129285
[TBL] [Abstract][Full Text] [Related]
3. Serum Levels of Biomarkers of Immune Activation and Associations With Neurological Impairment in Relapsing-Remitting Multiple Sclerosis Patients During Remission.
Witkowska AM; Socha K; Kochanowicz J; Karpińska E; Jakoniuk M; Zujko ME; Wilkiel M; Borawska MH; Mariak Z
Biol Res Nurs; 2016 Jan; 18(1):113-9. PubMed ID: 25911236
[TBL] [Abstract][Full Text] [Related]
4. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
[TBL] [Abstract][Full Text] [Related]
5. The role of Th17 cells in patients with relapsing-remitting multiple sclerosis: interleukin-17A and interleukin-17F serum levels.
Babaloo Z; Aliparasti MR; Babaiea F; Almasi S; Baradaran B; Farhoudi M
Immunol Lett; 2015 Apr; 164(2):76-80. PubMed ID: 25625963
[TBL] [Abstract][Full Text] [Related]
6. Alterations in serum levels of IL-17 in contrast to TNF-alpha correspond to disease-modifying treatment in relapsing-remitting multiple sclerosis.
Trenova AG; Slavov GS; Manova MG; Draganaova-Filipova MN; Mateva NG; Miteva LD; Stanilova SA
Scand J Clin Lab Invest; 2017 Jul; 77(4):283-288. PubMed ID: 28319417
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of serum human epididymis protein 4 in patients with relapsing-remitting multiple sclerosis.
Adamczyk B; Partyka R; Adamczyk-Sowa M; Wierzbicki K; Sowa P; Kokocińska D
Adv Clin Exp Med; 2020 Aug; 29(8):943-948. PubMed ID: 32790249
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.
Thouvenot E; Orsini M; Daures JP; Camu W
Eur J Neurol; 2015 Mar; 22(3):564-9. PubMed ID: 25530281
[TBL] [Abstract][Full Text] [Related]
9. A Pilot Cross-Sectional Study to Investigate the Biomarker Potential of Phosphorylated Neurofilament-H and Immune Mediators of Disability in Patients With 5 Year Relapsing-Remitting Multiple Sclerosis.
Herrera MI; Kölliker-Frers RA; Otero-Losada M; Perez Lloret S; Filippo M; Tau J; Capani F; Villa AM
Front Neurol; 2019; 10():1046. PubMed ID: 31649604
[No Abstract] [Full Text] [Related]
10. Insulin-like growth factor (IGF)-I and IGF-binding protein-3 serum levels in relapsing-remitting and secondary progressive multiple sclerosis patients.
Lanzillo R; Di Somma C; Quarantelli M; Ventrella G; Gasperi M; Prinster A; Vacca G; Pivonello C; Orefice G; Colao A; Morra VB
Eur J Neurol; 2011 Dec; 18(12):1402-6. PubMed ID: 21585623
[TBL] [Abstract][Full Text] [Related]
11. Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register.
Lepore V; Bosetti C; Santucci C; Iaffaldano P; Trojano M; Mosconi P;
Eur J Neurol; 2021 Feb; 28(2):567-578. PubMed ID: 33058344
[TBL] [Abstract][Full Text] [Related]
12. Association of seasonal serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple sclerosis.
Brola W; Sobolewski P; Szczuchniak W; Góral A; Fudala M; Przybylski W; Opara J
Eur J Clin Nutr; 2016 Sep; 70(9):995-9. PubMed ID: 27026420
[TBL] [Abstract][Full Text] [Related]
13. Serum apelin levels: clinical association with vascular involvements in patients with systemic sclerosis.
Aozasa N; Asano Y; Akamata K; Noda S; Masui Y; Yamada D; Tamaki Z; Tada Y; Sugaya M; Kadono T; Sato S
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):37-42. PubMed ID: 22112232
[TBL] [Abstract][Full Text] [Related]
14. Balance Changes in Patients With Relapsing-Remitting Multiple Sclerosis: A Pilot Study Comparing the Dynamics of the Relapse and Remitting Phases.
Findling O; Rust H; Yaldizli Ö; Timmermans DPH; Scheltinga A; Allum JHJ
Front Neurol; 2018; 9():686. PubMed ID: 30186223
[No Abstract] [Full Text] [Related]
15. Growth hormone response to clonidine administration for evaluation of autonomic dysfunction in multiple sclerosis patients.
Petrescu S; Trifanescu R; Ionescu P; Vanghelie GD; Tanasescu R; Moldovan M; Munjev N; Bajenaru O; Panea C
Maedica (Bucur); 2013 Mar; 8(1):11-6. PubMed ID: 24023592
[TBL] [Abstract][Full Text] [Related]
16. Serum 25(OH) Vitamin D levels is not associated with disability in multiple sclerosis patients: A case-control study.
Nikanfar M; Taheri-Aghdam AA; Yazdani M; Shaafi S; Masoudian N; Akbari H; Youhanaee P; Abbaszadeh H
Iran J Neurol; 2015 Jan; 14(1):17-21. PubMed ID: 25874052
[TBL] [Abstract][Full Text] [Related]
17. Retinal nerve fiber layer thickness and neurologic disability in relapsing-remitting multiple sclerosis.
Behbehani R; Al-Hassan AA; Al-Khars A; Sriraman D; Alroughani R
J Neurol Sci; 2015 Dec; 359(1-2):305-8. PubMed ID: 26671132
[TBL] [Abstract][Full Text] [Related]
18. Neutralizing antibody production against Rebif® and ReciGen® in Relapsing-Remitting Multiple Sclerosis (RRMS) patients and its association with patient's disability.
Shokrollahi Barough M; Ashtari F; Sadat Akhavi M; Asghari N; Mosayebi G; Mirmohammadkhani M; Kokhaei N; Bahraminia F; Ajami A; Kokhaei P
Int Immunopharmacol; 2018 Sep; 62():109-113. PubMed ID: 29990690
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D and disability in relapsing-remitting multiple sclerosis in patients with a Mexican background.
Rito Y; Flores J; Fernández-Aguilar A; Escalante-Membrillo C; Barboza MA; Amezcua L; Corona T
Acta Neurol Belg; 2018 Mar; 118(1):47-52. PubMed ID: 28975580
[TBL] [Abstract][Full Text] [Related]
20. Serum Tumor Necrosis Factor-Alpha Levels Correlate with Cognitive Function Scales Scores in Multiple Sclerosis Patients.
El-Salem K; Al-Mistarehi AH; Hanan Khalil ; Alham Al-Sharman ; Yassin A
Mult Scler Relat Disord; 2021 Jan; 47():102621. PubMed ID: 33197871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
